{"id":14307,"date":"2023-09-14T08:40:56","date_gmt":"2023-09-14T08:40:56","guid":{"rendered":"https:\/\/kraios.app\/news\/saglik\/2023\/09\/14\/50-70-yas-arasi-erkeklere-prostat-kanserine-karsi-yilda-bir-kez-kan-testi-uyarisi\/"},"modified":"2023-09-14T08:40:56","modified_gmt":"2023-09-14T08:40:56","slug":"50-70-yas-arasi-erkeklere-prostat-kanserine-karsi-yilda-bir-kez-kan-testi-uyarisi","status":"publish","type":"post","link":"https:\/\/kraios.app\/news\/saglik\/2023\/09\/14\/50-70-yas-arasi-erkeklere-prostat-kanserine-karsi-yilda-bir-kez-kan-testi-uyarisi\/","title":{"rendered":"50-70 ya\u015f aras\u0131 erkeklere, prostat kanserine kar\u015f\u0131 y\u0131lda bir kez kan testi uyar\u0131s\u0131"},"content":{"rendered":"<p><\/p>\n<div>\n<p>Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 Dr. Abdurrahman Yurtaslan Ankara Onkoloji E\u011fitim ve Ara\u015ft\u0131rma Hastanesi \u00dcroloji Klini\u011fi E\u011fitim ve \u0130dari Sorumlusu Prof. Dr. Halil Ba\u015far, 15 Eyl\u00fcl Prostat Kanseri Fark\u0131ndal\u0131k G\u00fcn\u00fc kapsam\u0131nda, AA muhabirine yapt\u0131\u011f\u0131 a\u00e7\u0131klamada, prostat kanserinin 50-65 ya\u015f aral\u0131\u011f\u0131ndaki erkeklerin y\u00fczde 25&#8217;inde g\u00f6r\u00fclen bir kanser oldu\u011funu, her 8 erkekten birinin risk ta\u015f\u0131d\u0131\u011f\u0131n\u0131 belirtti.<\/p>\n<p>Hastal\u0131\u011f\u0131n erken evrelerinde \u00f6zel bir semptomu olmad\u0131\u011f\u0131na ve \u00e7ok sinsi ilerledi\u011fine dikkati \u00e7eken Ba\u015far, hastalar\u0131n genellikle gece s\u0131k idrara \u00e7\u0131kma, g\u00fcnd\u00fczleri birka\u00e7 saat aral\u0131klarla tuvalete gitme, idrar\u0131n ince gelmesi gibi belirtilerle hastaneye ba\u015fvurdu\u011funu aktard\u0131.<\/p>\n<p>Prof. Dr. Ba\u015far, &#8220;O \u015fikayetler ba\u015flamadan hastay\u0131 fark etmek, yakalamak istiyoruz. Hastal\u0131\u011f\u0131n semptom ve belirtileri \u00e7ok ge\u00e7 evrede ortaya \u00e7\u0131k\u0131yor. Her ne kadar bizim yakla\u015f\u0131m\u0131m\u0131z kemoterapi, radyoterapiyle oluyorsa da hasta k\u00fcratif tedavi \u015fans\u0131n\u0131 yitirmi\u015f oluyor.&#8221; diye konu\u015ftu.<\/p>\n<p>Prostat kanserinin tedavisinde de erken tan\u0131n\u0131n \u00f6nemli oldu\u011funa i\u015faret eden Ba\u015far, &#8220;Prostat kanserini erkenden te\u015fhis etmek i\u00e7in bug\u00fcn elimizde PSA testi var. Bu testle hastal\u0131\u011f\u0131, daha milimetrik boyutlardayken tespit ediyoruz. Hastal\u0131k yay\u0131lmadan y\u00fczde 90 \u00fczeri ba\u015far\u0131yla tedavi ediyoruz&#8221; dedi.<\/p>\n<h3>&#8220;Erkekler randevu almadan klini\u011fe gelip tarama muayenesi yapt\u0131rabilir&#8221;<\/h3>\n<p>Prof. Dr. Ba\u015far, hastanede Haziran ay\u0131 itibar\u0131yla &#8220;Prostat Kanseri Tarama ve Takip Poliklini\u011fi&#8221;ni hayata ge\u00e7irdiklerini ve g\u00fcnde 15-20 ki\u015finin prostat kanseri taramas\u0131 i\u00e7in poliklini\u011fe ba\u015fvurdu\u011funu bildirdi.<\/p>\n<p>Erkeklerin randevu almadan klini\u011fe gelerek tarama muayenesi yapt\u0131rabileceklerini aktaran Ba\u015far, \u015fu uyar\u0131larda bulundu:<\/p>\n<p>&#8220;Genelde rektal muayeneden rahats\u0131z olundu\u011fu i\u00e7in \u00e7ekince ya\u015fan\u0131yor. Ancak buna ihtiya\u00e7 duymadan kandaki PSA de\u011ferine bakarak hastal\u0131\u011f\u0131 tespit edebiliyoruz. En \u00e7ok 50-70 ya\u015f aral\u0131\u011f\u0131ndaki hastalar\u0131 \u00f6nemsiyoruz. \u00c7\u00fcnk\u00fc hastalar\u0131m\u0131za erken tan\u0131 imkan\u0131n\u0131 vermek istiyoruz. 50-70 ya\u015f aral\u0131\u011f\u0131ndaki erkeklerin y\u0131lda bir defa tarama yapt\u0131rarak kanlar\u0131nda PSA de\u011ferine bakt\u0131rmalar\u0131 gerekiyor.&#8221;<\/p>\n<p>                            <span class=\"detay-foto-editor\">&#13;<br \/>\n                                <a href=\"https:\/\/www.aa.com.tr\/tr\/p\/abonelik-talep-formu\/1001\" target=\"_blank\" style=\"font-size:12px; color:#444; text-decoration:none;\" rel=\"noopener\">&#13;<br \/>\n                                    Anadolu Ajans\u0131 web sitesinde, AA Haber Ak\u0131\u015f Sistemi (HAS) \u00fczerinden abonelere sunulan haberler, \u00f6zetlenerek yay\u0131mlanmaktad\u0131r. <b style=\"color:#1897F7\">Abonelik i\u00e7in l\u00fctfen ileti\u015fime ge\u00e7iniz.<\/b>&#13;<br \/>\n                                <\/a>&#13;<br \/>\n                            <\/span>\n                        <\/div>\n<p><script>\n\t  window.fbAsyncInit = function() {\n\t\tFB.init({\n\t\t  appId: '1855843514662870',\n\t\t  status : true, \/\/ check login status\n\t\t  cookie : true, \/\/ enable cookies to allow the server to access the session\n\t\t  xfbml  : true  \/\/ parse XFBML\n\t\t});\n\t  };<\/p>\n<p>\t  (function() {\n\t\tvar e = document.createElement('script');\n\t\te.src=\"https:\/\/connect.facebook.net\/tr_TR\/all.js\";\n\t\te.async = true;\n\t\tdocument.getElementById('fb-root').appendChild(e);\n\t  }());\n    <\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 Dr. Abdurrahman Yurtaslan Ankara Onkoloji E\u011fitim ve Ara\u015ft\u0131rma Hastanesi \u00dcroloji Klini\u011fi E\u011fitim ve \u0130dari Sorumlusu Prof. Dr. Halil Ba\u015far, 15 Eyl\u00fcl Prostat Kanseri Fark\u0131ndal\u0131k G\u00fcn\u00fc kapsam\u0131nda, AA muhabirine yapt\u0131\u011f\u0131 a\u00e7\u0131klamada, prostat kanserinin 50-65 ya\u015f aral\u0131\u011f\u0131ndaki erkeklerin y\u00fczde 25&#8217;inde g\u00f6r\u00fclen bir kanser oldu\u011funu, her 8 erkekten birinin risk ta\u015f\u0131d\u0131\u011f\u0131n\u0131 belirtti. Hastal\u0131\u011f\u0131n erken evrelerinde \u00f6zel [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":14308,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":[],"categories":[46],"tags":[],"_links":{"self":[{"href":"https:\/\/kraios.app\/news\/wp-json\/wp\/v2\/posts\/14307"}],"collection":[{"href":"https:\/\/kraios.app\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kraios.app\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kraios.app\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kraios.app\/news\/wp-json\/wp\/v2\/comments?post=14307"}],"version-history":[{"count":0,"href":"https:\/\/kraios.app\/news\/wp-json\/wp\/v2\/posts\/14307\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kraios.app\/news\/wp-json\/wp\/v2\/media\/14308"}],"wp:attachment":[{"href":"https:\/\/kraios.app\/news\/wp-json\/wp\/v2\/media?parent=14307"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kraios.app\/news\/wp-json\/wp\/v2\/categories?post=14307"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kraios.app\/news\/wp-json\/wp\/v2\/tags?post=14307"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}